MicroRNA-219 loaded chitosan nanoparticles for treatment of glioblastoma

Rawan Alswailem, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Bahauddeen M. Alrfaei, Mohammad Badran, Qamraa H. Alqahtani, Hosam Gharib Abdelhady, Ibrahim A. Alsarra

Artificial Cells Nanomedicine and Biotechnology · 2022 · 41 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

release study demonstrated sustained release pattern of miR-219 from CS-NPs. Gel retardation assay has confirmed the integrity of miR-219 after production process. The fabricated NPs reduced the survival of U87 MG cells to 78% after 24 h of post-transfection, and into 67.5% after 48 h. However, fibroblasts were not affected by the NPs, revealing their specificity for GBM cells. Given the tumour suppressing function of miR-219, and advantage of CS-NPs for gene delivery to the central nervous system, the presented NPs have a great potential for treatment of GBM.

References

40